FDA Clearance Tracker · P820060-S001
ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
Last checked: Nov 20, 2026Latest source record: Aug 31, 1983 (this decision)Source: openFDAMethods & limitations
Decided
Aug 31, 1983
Approved
Time to decision
56 days
Received Jul 6, 1983. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Device class
Class II
The decision
- FDA number
- P820060-S001
- Device name
- ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
- Applicant
- Abbott Laboratories
- Applicant location
- Abbott Park, IL
- Received
- Jul 6, 1983
- Decided
- Aug 31, 1983
- Decision
- Approved
- Original approval
- P820060
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.6010
- Specialty
- Laboratory Medicine & Pathology
Source documents
Other decisions for Abbott Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Anti-HCV Next510(k)
K262156 · Decided Sep 23, 2026 · 89 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
- Anti-HCV Next510(k)
K252424 · Decided Apr 28, 2026 · 270 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
- ARCHITECT iGentamicin510(k)
K243500 · Decided Jul 9, 2025 · 239 days after receipt
Device type: Enzyme Immunoassay, Gentamicin (LCD) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.